Risk Disclaimer

The positions in this portfolio are incredibly risky and extremely volatile.

No one at Get Irked is a professional financial adviser (or a doctor), so consult with your own financial adviser to see if any of these positions fit your risk profile (and stomach).

Can. Palladium (DCNNF)

Despite gold and silver finally seeing a reasonable pop this week, Canadian Palladium (DCNNF) and the rest of my Super-Spec commodities plays came under fire this week with DCNNF taking the brunt of it.

DCNNF dropped to the tune of -13.85%, easily locking in the spot of the Week’s Biggest Loser.

Canadian Palladium (DCNNF): Added to Position

Canadian Palladium Resources (DCNNF) has been slamming down for the past few weeks, and it finally triggered my buy order which filled on Wednesday at $0.0606.

The buy lowered my per-share cost -7.20% from $0.0889 to $0.0825. From here, my next buy target is quite a bit lower from these levels, slightly above a past point of support, at $0.0469. My next sell target is near DCNNF’s high from earlier in 2021 with a target of $0.1427.

**WARNING** Canadian Palladium and the rest of the Super-Spec Basket are incredibly speculative. They should be viewed the same way a reasonable person might view a lottery ticket – I fully expect to lose all the money I put into any of the three and am risking a tiny amount of money, even for the Speculation in Play portfolio’s already small allocation sizes.

DCNNF closed the week at $0.056, down -7.59% from where I added Wednesday.

Chevron (CVX): *Removal from Coverage*

Chevron (CVX) has been quite a successful speculative investment for me with three equal buys at $76.94, $67.24, and $55.56 from March 12-18, 2020 which gave me per-share cost of $66.58. With oil prices increasing, I don’t see myself adding to CVX, and have decided to, instead, remove it from coverage and roll it into my “non-active positions” like I did with General Electric (GE) earlier this year and Twitter (TWTR) earlier than that.

My non-active positions are ones where I’ve taken my capital plus significant profits out and I’m letting the rest run, however, I have no plans to actively manage the position by purchasing more shares so I no longer track them in my Speculation in Play blog posts (positions in the non-active part of the portfolio are reported weekly as part of the “Cash” position).

For CVX’s replacement, I’m adding super-speculative Danimer Scientific (DNMR) which you can read more about below.

CVX closed the week at $112.80, giving my position a lifetime gain of +168.04%.

Danimer Scientific (DNMR): *New Position*

Danimer Scientific, LLC (DNMR) is working on developing biodegradable plastic alternatives for use in a wide variety of plastic applications – think: bottles, straws, food containers, and more under the “Nodax” brand name.

Where did I hear about this company? Believe it or not, from a Stansberry Research webinar where they were shilling a high-priced stock analysis newsletter. Seems like the perfect fit to replace oil company Chevron (CVX) in my Speculation in Play portfolio, doesn’t it?

On Wednesday, I placed a buy order to open the position at $15.00. From here, my next buy target is $13.60 and I already have a sell target of $21.25, near DNMR’s recent high back a few months ago in August. 

The stock proceeded to pop significantly as a result of the end of the webinar. While potentially a “pump-and-dump” where shareholders force a news event in an effort to pump up the price of the stock where they then take profits on the unwitting new shareholders, I decided to take the chance since this is a speculative portfolio and my allocation sizes here are incredibly small.

DNMR closed the week at $14.73, down -1.80% from where I opened Wednesday.

Virgin Galactic (SPCE): Added to Position

Following last week’s news that Virgin Galactic (SPCE) would be delaying civilian flights for nearly a year to ensure safety and efficacy, the stock continued to sell off this week, triggering a buy order that filled on Monday at $19.04.

The buy locks in a -65.84% discount on shares I sold on June 25 for $55.74 and raises my per-share cost +$25.07 from -$56.17 to -$31.10. From here, my next buy target is $14.30, slightly above a past point of support. My next sell target is $57.20, slightly below its last high in late June.

Also, I am being very careful with my quantities so even if SPCE drops below its $6.90 all-time low, I will never put capital back into this position – only using profits to add to my position from here on. There are few things I hate more than during a win into a loss by buying up my per-share cost only to have the equity sell off below my new per-share cost and my original per-share cost (I’m looking at you Grow Generation (GRWG)!).

SPCE closed the week at $19.66, up +3.26% from where I added Monday.